论文部分内容阅读
目的观察静脉注射胺碘酮治疗心房纤颤快速心室率的疗效。方法选择由各种病因导致的心房纤颤心室率大于100次/min者90例,10min静脉注射胺碘酮150mg,观察10min,未转为窦性心律者再次10min推注150mg,仍未转复者则以每分钟0.5～1.2mg静脉输注24h,转为窦性心律者则随时终止输注,24小时未转复者停用。结果24h内转复为窦性心律者72人(80%)。转为窦性心律时间10min～23h,平均8h。转复为窦性心律的药物剂量150mg～1500mg,平均为750mg。无严重心律失常发生,未诱发或加重心功能不全。结论静脉注射胺碘酮治疗心房纤颤快速心室率疗效确切安全。
Objective To observe the curative effect of intravenous amiodarone on rapid ventricular rate of atrial fibrillation. Methods Ninety cases of ventricular rate of atrial fibrillation more than 100 beats / min caused by various causes were selected. Amiodarone 150 mg was administered intravenously 10 min, and observed for 10 min. Those who intravenous infusion of 0.5 ~ 1.2mg per minute for 24h, converted to sinus rhythm at any time to stop infusion, 24 hours without recovery disabled. Results 72 patients (80%) were converted to sinus rhythm in 24h. Converted to sinus rhythm 10min ~ 23h, an average of 8h. Turn into sinus rhythm drug dose 150mg ~ 1500mg, with an average of 750mg. No serious arrhythmia occurred, did not induce or aggravate heart failure. Conclusion intravenous amiodarone in the treatment of atrial fibrillation rapid ventricular rate is safe and safe.